FDA Science and Mission at Risk

This report by the Subcommittee on Science and Technology provides the context within which the FDA operates. The Subcommittee found substantial weaknesses across the Agency, with the possible exception of some drug and medical device review functions funded by industry user fees. There are several areas of greatest concern, however, which form the basis for this report’s most significant findings.

By Subcommittee on Science and Technology